Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Myopia control is not just for children with progressive myopia; it can be applied to adults and pre-myopes as well, according to a speaker at Vision Expo.“[There are] two things I want you to be ...

Artificial intelligence models hold incredible potential in the diagnosis, risk factor assessment, and prediction of the outcomes of myopia Myopia, or nearsightedness, affects two billion people ...

The Aston University academic explored the use of atropine for myopia control during her 100% Optical presentation ...

In September 2025, a first-of-its-kind medical device — glasses — to prevent pediatric myopia was granted marketing authorization by the FDA. In a 2-year randomized controlled trial, the Essilor ...

Rates of childhood myopia have increased steadily over the past decade, with eye care professionals reporting that vision changes are appearing at younger ages. Astigmatism, which affects how light ...

The short-term use of atropine eye drops to treat myopia in children did not affect long-term visual outcomes, the prospective observational ATLAS study of participants from two randomized trials ...

"This is another significant step forward in our mission to take on myopia at a global scale," said Debbie Olive, Chief Commercial Officer, CooperVision. "For children and families affected, myopia ...

The World Health Organization warns that by 2030, 40% of the world's population will be nearsighted. In the U.S. alone, myopia rates have soared over the past 50 years, from 25% in 1971 to nearly 42% ...

The expansions underscore the company’s commitment to making evidence-based myopia management interventions accessible to eye care professionals (ECPs) and children worldwide. CooperVision expects to ...